OTC shake-up likely as regulators mull centralised clearing

ominous-clouds
The outlook is uncertain for OTC derivatives

With President Barack Obama’s healthcare bill finally passed, financial regulatory reform in the US is likely to move back up the political agenda in coming months. A major part of the reform effort focuses on over-the-counter derivatives, with a number of bills being debated by Congress that aim to formalise oversight and move a big chunk of the market onto exchanges. The plethora of bills that have come out make it difficult to foresee what the likely impact of final legislation will be, but d

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: